Business Description
GemVax & KAEL Co Ltd
NAICS : 334413
SIC : 3674
ISIN : KR7082270000
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.91 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | -0.7 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.43 | |||||
Beneish M-Score | -5.58 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.5 | |||||
3-Year EPS without NRI Growth Rate | -42.9 | |||||
3-Year Book Growth Rate | -7.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.14 | |||||
9-Day RSI | 38.27 | |||||
14-Day RSI | 43.83 | |||||
6-1 Month Momentum % | -21.04 | |||||
12-1 Month Momentum % | -20.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.39 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.96 | |||||
Days Inventory | 66.66 | |||||
Days Sales Outstanding | 27 | |||||
Days Payable | 20.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.58 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.19 | |||||
Operating Margin % | -32.41 | |||||
Net Margin % | -78.06 | |||||
FCF Margin % | -14.42 | |||||
ROE % | -49.54 | |||||
ROA % | -40.1 | |||||
ROIC % | -20.49 | |||||
ROC (Joel Greenblatt) % | -135.43 | |||||
ROCE % | -46.36 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.01 | |||||
PB Ratio | 5.82 | |||||
Price-to-Tangible-Book | 6.23 | |||||
EV-to-EBIT | -7.85 | |||||
EV-to-EBITDA | -8.49 | |||||
EV-to-Revenue | 6.08 | |||||
EV-to-FCF | -45.97 | |||||
Price-to-Median-PS-Value | 0.74 | |||||
Earnings Yield (Greenblatt) % | -12.73 | |||||
FCF Yield % | -2.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
GemVax & KAEL Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 71,262.817 | ||
EPS (TTM) (â‚©) | -1413 | ||
Beta | 0.63 | ||
Volatility % | 23.24 | ||
14-Day RSI | 43.83 | ||
14-Day ATR (â‚©) | 449.087488 | ||
20-Day SMA (â‚©) | 11123.5 | ||
12-1 Month Momentum % | -20.75 | ||
52-Week Range (â‚©) | 10220 - 15310 | ||
Shares Outstanding (Mil) | 39.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GemVax & KAEL Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GemVax & KAEL Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
GemVax & KAEL Co Ltd Frequently Asked Questions
What is GemVax & KAEL Co Ltd(XKRX:082270)'s stock price today?
When is next earnings date of GemVax & KAEL Co Ltd(XKRX:082270)?
Does GemVax & KAEL Co Ltd(XKRX:082270) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |